Discover Tenders by Peptic Substances Sector

Find the most relevant tenders for Peptic Substances. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Peptic Substances tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Peptic Substances tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Tobramycin Excl Hard Capsules With Powder For Inhalation Obo Atc J01Gb01 For The Period From 01 12 24 To

Deadline: 05 Oct 2026

Germany

Ref. No.: 9651914

EMD:Ref Document

Bid Value: Ref Document

168 Days Left

Dla Emergent Iv Research And Development Program

Deadline: 12 Jun 2027

United States

Ref. No.: 9485985

EMD:Ref Document

Bid Value: Ref Document

418 Days Left

Pharmaceutical Discount Agreements From 01 12 2024 For Various Active Ingredients As Part Of An Open House Procedure

Deadline: 01 Oct 2026

Germany

Ref. No.: 9416150

EMD:Ref Document

Bid Value: Ref Document

164 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Timolol Brinzolamide Atc S01Ed67 Obg For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8801281

EMD:Ref Document

Bid Value: Ref Document

138 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Interferon Beta 1A Exclusively For Subcutaneous Use Atc L03Ab07 For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8798282

EMD:Ref Document

Bid Value: Ref Document

138 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Ciclosporin S01Xa18

Deadline: 10 Aug 2026

Germany

Ref. No.: 8790550

EMD:Ref Document

Bid Value: Ref Document

112 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lanreotide Atc H01Cb03 Obo For The Period 01 11 2024 31 10 2025 Plus Extension Option 1X12 Months

Deadline: 05 Sep 2026

Germany

Ref. No.: 8788391

EMD:Ref Document

Bid Value: Ref Document

138 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Minoxidil Atc C02Dc01 Obg For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8780394

EMD:Ref Document

Bid Value: Ref Document

138 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Thalidomide Atc L04Ax02 Obg For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8779622

EMD:Ref Document

Bid Value: Ref Document

138 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Nadroparin Atc B01Ab06 Obg For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8778724

EMD:Ref Document

Bid Value: Ref Document

138 Days Left

Support Housing For Addiction Problems

Deadline: 01 Apr 2027

Sweden

Ref. No.: 8766770

EMD:Ref Document

Bid Value: Ref Document

346 Days Left

Residential Substance Misuse Services

Deadline: 31 Mar 2032

Great Britain

Ref. No.: 8663191

EMD:Ref Document

Bid Value: Ref Document

2172 Days Left

Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure

Deadline: 01 Sep 2026

Germany

Ref. No.: 8564108

EMD:Ref Document

Bid Value: Ref Document

134 Days Left

Rfp J25092 Provide Juvenile Drug Court Substance Abuse Treatment

Deadline: 30 Jun 2027

United States

Ref. No.: 8332502

EMD:Ref Document

Bid Value: Ref Document

436 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Omalizumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 8294730

EMD:Ref Document

Bid Value: Ref Document

112 Days Left

Showing 2386 to 2400 of 2472 results

Discover Tenders by Peptic Substances Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Peptic Substances Sector

Filter Your Search

FREE Trial plan for all new users!